Sepsis Diagnostics Market Will Reach USD 1,109.0 Million by 2030 | P&S Intelligence

The total value of the global sepsis diagnostics market was USD 548.2 million in 2022, and it will rise at a growth rate of above 9.2% shortly, reaching USD 1,109.0 million by 2030. This growth can be attributed to the growing cases of hospital-acquired infections and sepsis and the numerous steps taken by healthcare and also government establishments to aid the research activities associated with its finding.

All admitted patients are susceptible to nosocomial contagion. The main risk reasons for such infections are the utilization of indwelling catheters, extended infirmary stays, overdoing of antibiotics, and fault of the healthcare workers to sanitize their hands. Moreover, HAIs kill more individuals every year worldwide than breast cancer, car accidents, and AIDS. Therefore, there is an extreme requirement to control HAIs.

Download sample copy of this report: https://www.psmarketresearch.com/market-analysis/sepsis-diagnostic-market/report-sample

In 2022, the microbiology category generated the largest revenue share, approximately 50%. Via the utilization of culture media testing, including bacteriology tests, mycobacteriology tests, and serology tests, microbiology permits the measurable identification of microorganisms instigating sepsis.

In 2022, North America led the sepsis diagnostics market with approximately 40% share. This can be credited to the high mortality rates related to sepsis in the continent. Recently, an American government association specified that in an average year, 2 million Americans grow sepsis and 1 in 3 patients expire in hospitals following onset.

Hence, the growing cases of hospital-acquired infections and sepsis and the numerous steps taken by healthcare and also government establishments to aid the research activities associated with its finding are the major factors propelling the industry.

Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=sepsis-diagnostic-market

Market Size Breakdown by Segment

By Product
• Instruments
• Blood Culture Media
• Assay Kits and Reagents
• Software
By Technology
• Microbiology
• Molecular Diagnostics
• Immunoassays
• Flow Cytometry
• Others
By Pathogen
• Bacterial Sepsis
• Fungal Sepsis
• Viral Sepsis
• Others
Market Segmentation by Method
• Automated
• Conventional
Market Segmentation by Region
• North America Sepsis Diagnostics Market
o By product
o By technology
o By pathogen
o By method
o By country - U.S. and Canada
• Europe Sepsis Diagnostics Market
o By product
o By technology
o By pathogen
o By method
o By country - U.K., Germany, France, Spain, Italy, and Rest of Europe
• Asia-Pacific (APAC) Sepsis Diagnostics Market
o By product
o By technology
o By pathogen
o By method
o By country - China, India, Japan, and Rest of APAC
• Latin America (LATAM) Sepsis Diagnostics Market
o By product
o By technology
o By pathogen
o By method
o By country - Brazil, Mexico, and Rest of LATAM
• Middle East and Africa (MEA) Sepsis Diagnostics Market
o By product
o By technology
o By pathogen
o By method
o By country - Saudi Arabia, South Africa, and Rest of MEA

Contact:
Chandra Mohan
AVP - Business Development
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: https://healthcarefuturetrends.blogspot.com

About P&S Intelligence

P&S Intelligence offers custom and syndicated market research and consulting services to clients across the globe. Our team of young and dynamic researchers, guided by mentors with years of experience, create data-rich reports tailored to the needs of MNCs as well as startups and SMEs. We remain in a perennial quest to offer exhaustive insights into every aspect of the market, allowing businesses of all sizes to seize even the smallest of opportunities and tackle even the biggest of challenges.

This release was published on openPR.